Peripheral blood from 67 patients with non-Hodgkin's lymphoma was examined at initial diagnosis for the presence of circulating lymphoma cells by DNA 
Lymphoma cells can be identified in peripheral blood of patients with non-Hodgkin's lymphoma (NHL) by a number of techniques. They can be seen by simple morphological examination of peripheral blood smear in 8-20% of patients (Come et al., 1980; Dick et al., 1974; Foucar et al., 1982; McKenna et al., 1975; Morra et al., 1985) . The clonal nature of lymphoma allows for the detection of lymphoma cells by techniques relying on clonality. With the immunocytological technique of 'clonal excess' using ic/A staining combined with flow cytometry it is possible to identify a clonal lymphoid population in peripheral blood with 1-10% sensitivity (Berliner et al., 1986) . However, techniques relying on surface immunoglobulin are limited to B-cell lymphomas and the sensitivity depends on the degree of immunoglobulin expression.
Clonal immunoglobulin and T-cell receptor gene rearrangement can be detected by DNA hybridisation techniques with immunoglobulin and T-cell receptor gene probes as faint bands of rearrangement assumed to represent lymphoma cells (Brada, 1990) . Circulating lymphoma cells can be detected with 1-5% sensitivity (Brada et al., 1987; Knowles et al., 1987; Wright et al., 1987) , and this is more sensitive than the technique of clonal excess (Berliner et al., 1986) . The sensitivity can be markedly increased by the use of polymerase chain reaction (PCR). However, this requires either the presence of a specific translocation such as the t(14;18) or the knowledge of specific sequence around the gene rearrangement site. The sensitivity reaches 1:105 and has been applied particularly to the study of low-grade lymphoma (Cotter et al., 1990) .
Despite extensive literature on the frequency and the techniques of detection of circulating lymphoma cells, there is little information on the clinical significance of these findings. The presence of clonal excess in remission seems to bear little relationship to the disease outcome, both in intermediateand high-grade lymphoma (Horning et al., 1990; Johnson et al., 1991) and in low-grade lymphoma when cells are detected with high sensitivity by PCR (Cotter et al., 1990; Price et al., 1991) . We based regimen in 10, MACOP-B in 13 and a chlorambucilbased regimen in two patients with follicular intermediategrade disease.
Patients were followed by clinical examination, routine chest radiograph, and blood count. The median follow-up was 31 years (range 11 months to 7 years). Disease recurrence or progression was determined by clinical examination and imaging. Progression-free survival (PFS) and survival were measured from the date of diagnosis and were calculated by the actuarial method (Peto et al., 1977) . Patients on initial surveillance had PFS measured from the date of starting therapy. Comparison between subgroups was made by log-rank analysis (Peto et al., 1977) and the independent prognostic significance was tested using the Cox regression model (Cox et al., 1972) .
Methods of detection of lymphoma cells
A 20 ml sample of peripheral blood was seperated on Lymphoprep (Nycomed) density gradient and the mononuclear cell fraction isolated. DNA was extracted by conventional techniques and digested with appropriate restriction enzymes (EcoRI, HindIII, BamHI, BglII, PstI, XbaI) under the conditions recommended by the suppliers (Boehringer Mannheim). At least two different digests were performed for hybridisation with each of the probes. The DNA was fractionated on 0.7% agarose gels (BRL) together with positive and negative controls and appropriate size markers (lHindlII digest; Boehringer Mannheim), photographed, and transferred to nylon membrane (Hybond-N; Amersham International) by conventional Southern blotting. The DNA was fixed to the membranes using mid-range UV transillumination. The membranes were hybridised at 65°C for 16 h with the appropriate probes, previously labelled with 32P by the random primer extension method (Feinberg & Vogelstein et al., 1983) in a solution of 6 x SSPE (20 x SSPE: 0.17 M sodium phosphate, 2.98 M sodium chloride, 0.02 M EDTA), 5 x Denhardt's (1% bovine serum albumin, 1% Ficoll, 1% polyvinyl pyrrolidone), 5% dextran sulphate and 0.5% sodium dodecyl sulphate (SDS). Filters were washed to a stringency of 0.1 x SSPE at 650C. A circulating clone of cells was considered to be present if one or two rearranged bands in addition to germline bands were present on two separate enzyme digests. Where sufficient DNA was obtained tests were done for both immunoglobulin and T-cell receptor gene rearrangement, regardless of immunophenotype. In eight cases with insufficient DNA material the immunophenotype of the diagnostic lymph node was indicative of a B-cell malignancy, and the peripheral blood was examined only for rearrangements of the immunoglobulin genes.
Lymph node tissue for DNA analysis was snap frozen at biopsy and disaggregated by homogenisation. DNA was extracted and treated as for peripheral blood.
DNA probes To establish clonality of B cells JH probe, homologous to the joining region of the immunoglobulin heavy-chain gene (a gift from P. Leder), was used, which is present in both rearranged and unrearranged alleles (Ravetch et al., 1981) .
The T-cell receptor probe used was Cp1 (Furley et al., 1986 ) (a gift from T. Mak), homologous to the Cp1 region of the P-chain of the T-cell receptor gene, which is expressed as an o4p dimer in 90% of T cells (Elliot et-al., 1988 (Table IV) . In patients with low-grade lymphoma the 3-year progression-free survival was 8% in 12 patients with clonal rearrangement and 38% in 14 patients without (P <0.01). Discussion DNA hybridisation studies of the mononuclear cell fraction from peripheral blood of patients with non-Hodgkin's lymphoma detect clonal rearrangement of immunoglobulin and T-cell receptor genes. In ten patients in this study lymphoma tissue was available for analysis, and in four cases in which rearrangement was found in peripheral blood this was identical to that in the lymphoma tissue. This is similar to previous findings and indicates that such gene rearrangement represents lymphoma cells (Brada et al., 1987; Hu et al., 1985) . As shown previously, the sensitivity of detection of lymphoma cells was 1-5% (Berliner et al., 1986; Brada et al., 1987; Horning et al., 1990 ). The overall frequency of detection of lymphoma cells (31%) compares with other studies (Brada et al., 1987; Horning et al., 1990; Johnson et al., 1991) , which suggest that similar sensitivity was retained. The rate of detection correlated with stage, histological grade and the presence of bone marrow involvement as reported previously (Brada et al., 1987; Homing et al., 1990) . Although the presence of circulating cells was related to the stage of disease and bone marrow involvement, a number of patients with early stage disease and without bone marrow involvement had clonal rearrangement in peripheral blood.
The distribution of patients by stage, histological grade and age broadly reflects the spectrum of the lymphoma patient population (DeVita et al., 1985) . Although the treatment in terms of individual regimens was not uniform, most patients with intermediate-and high-grade lymphoma were treated with anthracycline-containing chemotherapy and patients with localised disease were treated with combined chemotherapy and radiotherapy. Only five patients with local disease were treated with radiotherapy alone. Treatment of low-grade NHL also followed established practice. Half of the patients with advanced low-grade lymphoma were subjected to a policy of initial observation, while a third received initial chemotherapy. Patients with localised low-grade NHL were treated with radiotherapy alone. The prognostic influence of stage and histology reflects the prognostic factors found in other studies, although the limited number of patients precludes a more exhaustive analysis.
The detection of lymphoma cells in peripheral blood correlated with poor disease control in the whole group and in those with intermediate-and high-grade lymphoma. Multivariate analysis suggested that the presence of lymphoma cells is only a marginal independent prognostic factor for PFS in the combined group as it did not fully reach statistical significance. These findings are similar to those of Lindemalm et al. (1987) , who found that the detection of circulating lymphoma cells by clonal B-cell excess correlated with poor disease-free survival in patients with high-grade lymphoma. However, it is difficult to reconcile these data with the finding that the presence of lymphoma cells in patients in remission does not predict subsequent relapse (Homing et al., 1990 ).
Clones of lymphoma cells are found frequently in patients with low-grade NHL (Cotter et al., 1990 (Gribben et al., 1991) . The study of peripheral blood involvement in patients presenting with lymphoma using DNA technology should be included in large multicentre trials with uniform treatment to define the precise prognostic significance of these findings.
